Élise Dumas
-
- Cancer Risks and Factors 8
- Cancer Immunotherapy and Biomarkers 6
- Global Cancer Incidence and Screening 4
-
- Breast Cancer Treatment Studies 6
-
- Advanced Breast Cancer Therapies 2
- Cancer-related cognitive impairment studies 2
-
- Chronic Myeloid Leukemia Treatments 2
-
- Ovarian cancer diagnosis and treatment 2
- Co-authors
- Anne‐Sophie HamyFabien ReyalEnora LaasPaul GougisFloriane JochumJudicaël HottonBaptiste AbbarJean‐Philippe Spano
- Journals
- Journal of Clinical Oncology (1 paper)American Journal of Obstetrics and Gynecology (1 paper)British journal of surgery (1 paper)
- Partner nations
- FranceSwitzerlandIndia
In The Last Decade
Élise Dumas
20 papers receiving 189 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 124
- Health Informatics 2
- Endocrine and Autonomic Systems 10
- Toxicology 5
- Immunology 29
Countries citing papers authored by Élise Dumas
This map shows the geographic impact of Élise Dumas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élise Dumas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élise Dumas more than expected).
Fields of papers citing papers by Élise Dumas
This network shows the impact of papers produced by Élise Dumas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élise Dumas. The network helps show where Élise Dumas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Élise Dumas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspectivebreakdown → | 2024 | 67 |
| 8 | 2024 | 2 | |
| 9 | 2024 | 16 | |
| 10 | 2024 | 4 | |
| 11 | 2024 | 21 | |
| 12 | 2024 | 0 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 8 | |
| 15 | 2022 | 14 | |
| 16 | 2022 | 0 | |
| 17 | 2022 | 3 | |
| 18 | 2021 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2021 | 5 |
About Élise Dumas
Élise Dumas is a scholar working on Oncology, Cancer Research and Statistics and Probability, having authored 25 papers that have together received 195 indexed citations. Recurring topics across this work include Cancer Risks and Factors (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Breast Cancer Treatment Studies (6 papers), Global Cancer Incidence and Screening (4 papers), Advanced Breast Cancer Therapies (2 papers), Cancer-related cognitive impairment studies (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Oncology (124 citations), Health Informatics (2 citations) and Endocrine and Autonomic Systems (10 citations). Élise Dumas has collaborated with scholars based in France, Switzerland and India. Frequent co-authors include Anne‐Sophie Hamy, Fabien Reyal, Enora Laas, Paul Gougis, Floriane Jochum, Judicaël Hotton, Baptiste Abbar, Jean‐Philippe Spano, Joe‐Elie Salem and Kévin Bihan. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and British journal of surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.